CAMP4 Therapeutics
CAMP----
CAMP4 Therapeutics (CAMP)
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases....
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
CAMP4 Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 6, 2026Price forecast
$8.58150.97%
Forecast & RatingStrong buy
7analysts
- Strong buy71.43%
- Buy28.57%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 8 hours ago
Camp4 wins Australian clearance for Phase 1/2 CMP-002 trial in SYNGAP1-related disorder
- Unusual Whales · 9 hours ago
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
- benzinga_article · Jul 22 at 04:05 PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga_article · Jul 20 at 07:05 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Simplywall · Jul 18 at 08:05 AM
We Think Camp4 Therapeutics (NASDAQ:CAMP) Can Afford To Drive Business Growth
- GlobeNewswire · Jul 17 at 03:05 PM
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
